Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma

被引:6
作者
Midenberg, Eric [1 ]
Higgins, Michelle I. [2 ]
Schmeusser, Benjamin N. [1 ]
Patil, Dattatraya H. [1 ]
Zaldumbide, Joel [1 ]
Martini, Dylan J. [3 ]
Steele, Sean [1 ]
Williams, Milton [4 ]
Nabavizadeh, Reza [1 ]
Psutka, Sarah P. [5 ,6 ]
Ogan, Kenneth [1 ]
Bilen, Mehmet Asim [7 ,8 ]
Master, Viraj A. [1 ,8 ,9 ]
机构
[1] Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA
[2] Johns Hopkins Univ Hosp, Brady Urol Inst, Baltimore, MD USA
[3] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[4] Univ Alabama Birmingham, Dept Urol, Birmingham, AL USA
[5] Univ Washington, Dept Urol, Seattle, WA USA
[6] Seattle Canc Care Alliance, Seattle, WA USA
[7] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA
[8] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[9] Emory Univ, Dept Urol, 1365 Clifton Rd NE,Bldg B,Suite 1400, Atlanta, GA 30322 USA
关键词
Sarcopenia; Body composition; Renal cell carcinoma; Nephrectomy; Nutrition; Albumin; RADICAL NEPHRECTOMY; BODY-COMPOSITION; MUSCLE MASS; OBESITY; HYPOALBUMINEMIA; ASSOCIATION; MORTALITY; SURVIVAL; CACHEXIA;
D O I
10.1016/j.urolonc.2022.09.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: A universally accepted model for preoperative surgical risk stratification in localized RCC patients undergoing nephrec-tomy is currently lacking. Both the evaluation of body composition and nutritional status has demonstrated prognostic value for patients with cancer. This study aims to investigate the potential associations between sarcopenia and hypoalbuminemia and survival outcomes in patients with localized kidney cancer treated with partial or radical nephrectomy. Materials and Methods: We retrospectively analyzed 473 patients with localized RCC managed with radical and partial nephrectomy. Skeletal muscle index (SMI) was measured from preoperative CT and MRI. Sarcopenic criteria were created using BMI-and sex-stratified thresholds. Relationships between sarcopenia and hypoalbuminemia (Albumin < 3.5 g/dL) with overall (OS), recurrence-free (RFS), and cancer-specific survival (CSS) were determined using multivariable and Kaplan-Meier analysis. Results: Of the 473 patients, 42.5% were sarcopenic and 24.5% had hypoalbuminemia. Sarcopenia was significantly associated with shorter OS (HR=1.51, 95% CI 1.07-2.13), however, was nonsignificant in the RFS (HR =1.33, 95% CI 0.88-2.03) and CSS (HR=1.66, 95% CI 0.96-2.87) models. Hypoalbuminemia predicted shorter OS (HR=1.76, 95% CI 1.22-2.55), RFS (HR=1.86, 95% CI 1.19-2.89), and CSS (HR=1.82, 95% CI 1.03-3.22). Patients were then stratified into low, medium, and high-risk groups based on the severity of sarcopenia and hypoalbuminemia. Risk groups demonstrated an increasing association with shorter OS (all p < 0.05). Reduced RFS was observed in the medium risk-hypoalbuminemia (HR=2.18, 95% CI 1.16-4.09) and high-risk groups (HR=2.42, 95% CI 1.34-4.39). Shorter CSS was observed in the medium risk-hypoalbuminemia (HR=2.31, 95% CI 1.00-5.30) and high-risk groups (HR=2.98, 95% CI 1.34-6.61). Conclusion: Localized RCC patients with combined preoperative sarcopenia and hypoalbuminemia displayed a two to a three-fold reduction in OS, RFS, and CSS after nephrectomy. These data have implications for guiding prognostication and treatment election in local-ized RCC patients undergoing extirpative surgery. (C) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页码:50.e19 / 50.e26
页数:8
相关论文
共 50 条
  • [41] Prognostic significance of modified Glasgow Prognostic Score in patients with non-metastatic clear cell renal cell carcinoma
    Cho, Dae Sung
    Kim, Sun Il
    Choo, Seol Ho
    Jang, Seok Heun
    Ahn, Hyun Soo
    Kim, Se Joong
    SCANDINAVIAN JOURNAL OF UROLOGY, 2016, 50 (03) : 186 - 191
  • [42] Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT
    Alongi, Pierpaolo
    Picchio, Maria
    Zattoni, Fabio
    Spallino, Marianna
    Gianolli, Luigi
    Saladini, Giorgio
    Evangelista, Laura
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (03) : 464 - 473
  • [43] Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma
    Teng Jingfei
    Gao Yi
    Chen Ming
    Wang Kai
    Cui Xingang
    Liu Yushan
    Xu Danfeng
    CHINESE MEDICAL JOURNAL, 2014, 127 (09) : 1640 - 1644
  • [44] Trends in Surgical Management of T1 Renal Cell Carcinoma
    Schiffmann, Jonas
    Bianchi, Marco
    Sun, Maxine
    Becker, Andreas
    CURRENT UROLOGY REPORTS, 2014, 15 (02)
  • [45] PROGNOSTIC VALUE OF NUCLEAR GRADE OF RENAL-CELL CARCINOMA
    BRETHEAU, D
    LECHEVALLIER, E
    DEFROMONT, M
    SAULT, MC
    RAMPAL, M
    COULANGE, C
    CANCER, 1995, 76 (12) : 2543 - 2549
  • [46] Update on contemporary management of clinically localized renal cell carcinoma
    Jorns, J. J.
    Thiel, D. D.
    Castle, E. P.
    MINERVA UROLOGICA E NEFROLOGICA, 2012, 64 (04) : 261 - 272
  • [47] Prognostic value of tissue-based biomarker signature in clear cell renal cell carcinoma
    Haddad, Ahmed Q.
    Luo, Jun-Hang
    Krabbe, Laura-Maria
    Darwish, Oussama
    Gayed, Bishoy
    Youssef, Ramy
    Kapur, Payal
    Rakheja, Dinesh
    Lotan, Yair
    Sagalowsky, Arthur
    Margulis, Vitaly
    BJU INTERNATIONAL, 2017, 119 (05) : 741 - 747
  • [48] Trends in Surgical Management of T1 Renal Cell Carcinoma
    Jonas Schiffmann
    Marco Bianchi
    Maxine Sun
    Andreas Becker
    Current Urology Reports, 2014, 15
  • [49] Prognostic factors in renal cell carcinoma
    Medina Lopez, Rafael A.
    Conde Sanchez, Jose M.
    Congregado Ruiz, Carmen B.
    Gonzalez Resina, Raquel
    Marmol Navarro, Salvador
    Torrubia Romero, Francisco J.
    ACTAS UROLOGICAS ESPANOLAS, 2009, 33 (05): : 575 - 583
  • [50] Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinoma
    Kuemmerl, Luca
    Kraulich, Matthias
    Lesyuk, Wladimir
    Binninger, Adrian
    Goebell, Peter J.
    Kahlmeyer, Andreas
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (09) : 392.e1 - 392.e9